News
06-03-2012, 09:41 PM
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
More... (http://www.news-medical.net/news/20120604/Affibody-GE-Healthcare-partner-to-develop-Her2-targeted-PET-imaging-agent.aspx)
More... (http://www.news-medical.net/news/20120604/Affibody-GE-Healthcare-partner-to-develop-Her2-targeted-PET-imaging-agent.aspx)